A Genetics Society Sectional Interest Group meeting
Evolutionary genetics is a fast moving field, where new technologies have resulted in a wealth of genomic data. The aim of this meeting is to promote the exchange of ideas and collaborations by bringing together participants from a range of backgrounds, including evolutionary biology, genetics and genomics, with a particular focus on work at the interface of genomics and evolutionary biology.
KEYNOTES
Professor Anne C. Stone
Regents’ Professor School of Human Evolution & Social Change
Arizona State University
Talk title: The evolutionary history of M. tuberculosis: insights from ancient DNA
Anne Stone is Regents’ Professor in the School of Human Evolution and Social Change at the Arizona State University. Currently, her research focuses on population history and understanding how humans and the great apes have adapted to their environments, including their disease and dietary environments. This includes: (a) Native American population history, (b) the evolutionary history of the Great Apes, and (c) understanding the evolutionary history of mycobacteria (specifically the causative agents of tuberculosis and leprosy). Stone has been a Fulbright Fellow (1992-93), a NIH NRSA postdoctoral fellow (1997-1998), and a Kavli Scholar (2007). She is a fellow of the American Association for the Advancement of Science (2011) and a member of the National Academy of Sciences (2016). Stone currently serves as a senior editor of Molecular Biology and Evolution.
Professor Charles Swanton FRCP PhD FMedSci, FRS
Director, CRUK Lung Cancer Centre of Excellence
Senior Group Leader, The Francis Crick Institute
Talk title: Cancer Evolution and Immune Escape: TRACERx.
Charles completed his MDPhD training in 1999 at the Imperial Cancer Research Fund
Laboratories and Cancer Research UK clinician scientist/medical oncology training in
2008. Charles combines his laboratory research at the Francis Crick Institute with
clinical duties at UCLH as director of the CRUK UCL Lung Cancer Centre, focussed
on how tumours evolve over space and time. Charles has helped to define the
branched evolutionary histories of solid tumours, processes that drive cancer cell-to-
cell variation in the form of new cancer mutations or chromosomal instabilities, and
the impact of such cancer diversity on effective immune surveillance and clinical
outcome.
Charles was made Fellow of the Royal College of Physicians in April 2011 and
appointed Fellow of the Academy of Medical Sciences in 2015. Charles was awarded
the Stand up to Cancer Translational Cancer Research Prize (2015), Glaxo Smithkline
Biochemical Society Prize (2016), San Salvatore prize for Cancer Research (2017)
and the Ellison-Cliffe Medal, Royal Society of Medicine (2017). Charles was
appointed Napier Professor in Cancer by the Royal Society in 2016. Charles was
elected EMBO member and was appointed the Cancer Research UK Chief Clinician
in 2017 and elected a Fellow of the Royal Society in 2018.
Professor Beverley Glover
Director of Cambridge University Botanic Garden
Department of Plant Sciences
University of Cambridge
Talk title: Flower evo-devo and the link to speciation
